Clinical trial
Efficacy and Nutritional Assessment Following Albendazole and Combined Albendazole/Ivermectin Treatment for Intestinal Helminth Infections in Rural Guatemalan Schoolchildren
NCT00207753 is registered in ClinicalTrials.gov with Centers for Disease Control and Prevention as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Nutritional Assessment Following Albendazole and Combined Albendazole/Ivermectin Treatment for Intestinal Helminth Infections in Rural Guatemalan Schoolchildren
- Lead sponsor
- Centers for Disease Control and Prevention
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 28, 2005
- Completion date
- March 31, 2005
- Enrollment
- 550
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ascariasis, hookworm infection, pediculosis, strongyloidiasis, trichuriasis